TickerFacts.

BioNexus Gene Lab Corp (BGLC): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$37.0K
Year ended 2025-12-31
$7.0K
Trailing 12 months to 2026-06-30
-38.5%
5-year compound annual growth
$421.6K2018-12-31: -$39.6K2019-12-31: $12.8K2020-12-31: $421.6K2021-12-31: $3.2K2022-12-31: $02023-12-31: $149.4K2024-12-31: $227.0K2025-12-31: $37.0K$37.0K
2018-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$37.0K-83.7%2026-04-14, From 2025-01-01
2024-12-31$227.0K+51.9%2026-04-14, From 2024-01-01
2023-12-31$149.4Kn/a2025-04-15, From 2023-01-01
2022-12-31$0-100.0%2024-04-16, From 2022-01-01
2021-12-31$3.2K-99.3%2023-03-31, From 2021-01-01
2020-12-31$421.6Kn/m2022-04-06, From 2020-01-01
2019-12-31$12.8Kn/c2021-03-30, From 2019-01-01
2018-12-31-$39.6Kn/a2020-03-31, From 2018-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
BioNexus Gene Lab Corp (BGLC)2025-12-31$37.0K-83.7%
American Shared Hospital Services (AMS)2025-12-31$7.63M-3.8%
Exagen Inc. (XGN)2025-12-31$641.0K+24.5%
Personalis, Inc. (PSNL)2025-12-31$4.50M+181.0%
Biodesix Inc (BDSX)2025-12-31$259.0K-92.0%
YD Bio Ltd (YDES)2025-12-31$1.44Mn/m
GRAIL, Inc. (GRAL)2025-12-31$909.0K-82.5%
BillionToOne, Inc. (BLLN)2025-12-31$8.88M+64.4%
Fulgent Genetics, Inc. (FLGT)2025-12-31$22.57M-44.0%

Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗